Case File
efta-efta01733938DOJ Data Set 10CorrespondenceEFTA Document EFTA01733938
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01733938
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
IN WITNESS WHEREOF, each of the parties hereto has executed this Second
Amendment to Series A Preferred Stock Purchase Agreement as of the date first set forth above.
COMPANY:
ADFIN SOLUTIONS, INC.
By:
Jeanne Houweling
President & CEO
STOCKHOLDERS:
JONATHAN LEITERSDORF
By:
Name: Jonathan Leitersdorf
DAVID J. MITCHELL
By:
Name: David J. Mitchell
SOUTHERN TRUST, INC.
By:
Jeffrey Epstein, President
WFSTt241590172.2
EFTA_R1_00010840
EFTA01733938
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.